The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBk. Cyprus Hldg Regulatory News (BOCH)

Share Price Information for Bk. Cyprus Hldg (BOCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 348.00
Bid: 346.00
Ask: 349.00
Change: 1.00 (0.29%)
Spread: 3.00 (0.867%)
Open: 350.00
High: 353.00
Low: 346.00
Prev. Close: 347.00
BOCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Tier 2 Capital Notes - Replacement

20 Apr 2021 14:23

RNS Number : 0666W
Bank of Cyprus Holdings PLC
20 April 2021
 

Announcement

 

Issue of Tier 2 Capital Notes

 

 

Nicosia, 16 April 2021

 

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014.

 

 

 

Bank of Cyprus Holdings Public Limited Company (the "Company" or "BOC Holdings" and, together with its subsidiary, Bank of Cyprus Public Company Limited (the "Bank"), and the Bank's subsidiaries, the "Group") announces today that the Company has successfully launched and priced an issue of €300 mn unsecured and subordinated Tier 2 Capital Notes (the "Notes") under its EMTN Programme.

 

The issue was met with strong demand, attracting interest from more than 140 institutional investors, with the final order book almost 4 times over-subscribed and final pricing 37.5 bps tighter from initial pricing indication. A number of long term, fundamental institutional investors participated in the offering for the first time, re-establishing the successful return of the Company to the institutional capital markets.

 

The Notes were priced at par with a fixed coupon of 6.625% per annum, payable annually in arrears and resettable on 23 October 2026. The maturity date for the Notes is 23 October 2031. The Company will have the option to redeem the Notes early on any day during the six-month period from 23 April 2026 to 23 October 2026, subject to applicable regulatory consents.

 

It is expected that settlement will occur on 23 April 2021. The Notes will be listed on the Luxembourg Stock Exchange's Euro MTF market.

 

In addition to the pricing of the issue of the Notes by the Company, the Bank has announced that it intends to purchase up to the total nominal amount of its €250 mn Fixed Rate Reset Tier 2 Capital Notes due January 2027 (ISIN: XS1551761569) at a purchase price of 105.50%, as more particularly described in a Tender Offer Memorandum dated 13 April 2021. Please click here for further details.

 

The issuance of the Notes further optimises the Group's capital structure and is expected to increase the Group's Total Capital ratio by c.100 bps to 19.7% pro forma for Helix 2. The issuance is expected to be fully MREL eligible, contributing towards the Bank's MREL requirements. 

 

The transaction has also enhanced the diversification of the Group's investor base, and the pricing outcome evidences market recognition of the significant progress made in evolving its financial profile.

 

Goldman Sachs International and HSBC acted as Global Coordinators and Dealer Managers, and together with BNP Paribas, Bank of America and JP Morgan acted as Joint Lead Managers. The Bank acted as Co-Manager.

 

For further information, please contact Investor Relations at investors@bankofcyprus.com.

 

[1] Based on the Group financial results as at 31 December 2020 pro forma for Helix 2.

 

 

 

 

Group Profile

 

The Bank of Cyprus Group is the leading banking and financial services group in Cyprus, providing a wide range of financial products and services which include retail and commercial banking, finance, factoring, investment banking, brokerage, fund management, private banking, life and general insurance. The Bank of Cyprus Group operates through a total of 95 branches in Cyprus, of which 11 operate as cash offices. Bank of Cyprus also has representative offices in Russia, Ukraine and China. The Bank of Cyprus Group employs 3,573 staff worldwide. At 31 December 2020, the Group's Total Assets amounted to €21.5 bn and Total Equity was €2.1 bn. The Bank of Cyprus Group comprises Bank of Cyprus Holdings Public Limited Company, its subsidiary Bank of Cyprus Public Company Limited and its subsidiaries.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IODSEDFDSEFSEFL
Date   Source Headline
9th May 20247:00 amRNSBOCH - Transactions in Own Shares
8th May 20247:06 amRNSTransaction in Own Shares
2nd May 20247:28 amRNSBOCH - Transactions in Own Shares
2nd May 20247:20 amRNSBOCH – Total voting rights and Capital
30th Apr 202410:19 amRNSAppointments of New Directors
30th Apr 20247:02 amRNSTransaction in Own Shares
29th Apr 20247:15 amRNSBOCH - Transactions in Own Shares
26th Apr 20241:21 pmRNSDate of announcement of 1Q2024 FR
26th Apr 20247:03 amRNSBOCH - Transactions in Own Shares
25th Apr 20247:26 amRNSBOCH - Transactions in Own Shares
25th Apr 20247:00 amRNSIssue of Green Senior Preferred Notes by BOC PCL
24th Apr 20247:00 amRNSBOCH - Transaction in Own Shares
24th Apr 20247:00 amRNSTR1 Notification - Helikon
24th Apr 20247:00 amRNSTR1 Notification -Helikon
23rd Apr 20247:25 amRNSBOCH - Transactions in Own Shares
22nd Apr 20247:27 amRNSBOCH - Transactions in Own Shares
19th Apr 20247:41 amRNSLaunch of share buyback programme
12th Apr 202410:02 amRNSNotice of AGM
5th Apr 20247:20 amRNS2023 Pillar 3 Disclosures
2nd Apr 20241:21 pmRNSTR1 Notification of Holdings - OSOME
2nd Apr 202412:59 pmRNSTR1 Notification of Holdings - OSOME
28th Mar 20242:24 pmRNSBOC Annual Financial Report 2023 Announcement
28th Mar 20241:31 pmRNSBOCH Annual Financial Report 2023 Announcement
28th Mar 20241:30 pmRNSFY2023 Investor Presentation Announcement
28th Mar 20241:30 pmRNSFY2023 Group Financial Results
20th Mar 20247:00 amRNSAnnouncement of Distribution
15th Mar 20249:21 amRNSDate of Announcement of Audited FY2023 FS
19th Feb 20247:01 amRNSDoc re. (Prelim FY2023 Investor Presentation)
19th Feb 20247:00 amRNSPreliminary FY2023 Group Financial Results
6th Feb 20248:41 amRNSDate of announcement of Preliminary FY2023 FR
22nd Dec 20239:09 amRNSRevised Date of AGM
20th Dec 20238:32 amRNSChanges in the composition of the BOD & Committees
13th Dec 20237:00 amRNSEU-wide Transparency Exercise 2023
11th Dec 20232:51 pmRNSChanges in the composition of the BOD
29th Nov 202310:28 amRNSDecision to call AT1 Capital Securities
29th Nov 20238:19 amRNSDate of Annual General Meeting
20th Nov 20239:58 amRNSAppointment of New Director
13th Nov 20237:00 amRNSDoc re. (9M2023 Investor Presentation)
13th Nov 20237:00 amRNS9M2023 Group Financial Results
27th Oct 20237:17 amRNSDate of announcement of 9M2023 FR
24th Oct 202312:41 pmRNSTR1 Notification - Caius
13th Oct 202312:27 pmRNSChanges in the composition of the BODs
27th Sep 20238:28 amRNSDirectorate Change
31st Aug 20237:37 amRNSChanges in the composition of BOD
11th Aug 20239:55 amRNSAppointment of new director
21st Jul 202310:43 amRNSDate of announcement of 1H2023 FR
18th Jul 20234:43 pmRNSIssue of Senior Preferred Notes
3rd Jul 202311:48 amRNSBuyback of Additional Tier 1 Capital Securities
23rd Jun 202312:48 pmRNSComposition of the Boards of Directors
20th Jun 202312:22 pmRNSResults of Additional Tier 1 Tender Cash Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.